http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107753535-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-236 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-236 |
| filingDate | 2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107753535-B |
| titleOfInvention | Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases and application thereof |
| abstract | The invention provides a pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, which comprises periplaneta americana and aspirin, and also comprises one or two of salvia miltiorrhiza and ligusticum wallichii, and further comprises the following components in parts by weight: 40-60 parts of periplaneta americana, 20-50 parts of salvia miltiorrhiza and 5-20 parts of aspirin; or the pharmaceutical composition comprises 40-60 parts of periplaneta americana, 20-50 parts of ligusticum wallichii and 5-20 parts of aspirin in parts by weight; or the pharmaceutical composition comprises 40-60 parts of periplaneta americana, 15-25 parts of salvia miltiorrhiza, 15-25 parts of ligusticum wallichii and 5-20 parts of aspirin in parts by weight. The pharmaceutical composition can effectively improve the gastric injury caused by long-term aspirin taking, and can effectively prevent the formation of thrombus while reducing the dosage of aspirin; reducing the formation of cerebral infarction and reducing the drug toxicity of aspirin. |
| priorityDate | 2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.